A Little Below the Belt magazine - Summer 2020

Page 40

Spotlight on testicular cancer The testes are two small organs found inside the scrotum, the pouch of skin behind the penis. They are part of the male reproductive system and are responsible for making sperm and are involved in producing a hormone called testosterone. Testosterone is an important hormone during male development and maturation and aids development of muscles, deepening of the voice, and growth of body hair.

30

928

estimated diagnoses

estimated deaths

in Australia in 2020

will result from testicular cancer in 2020

What is testicular cancer? Cancer that develops in a testicle is called testicular cancer or cancer of the testis. Usually only one testicle is affected, but in some cases both. About 90 to 95 per cent of testicular cancers start in the cells that develop into sperm - these are known as germ cells.

The five-year survival rate for men diagnosed with testicular cancer is close to 97.2 per cent. And in 2020, it is estimated there will be 30 deaths from testicular cancer.

Testicular cancer symptoms

Compared with other types of cancer, testicular cancer is rare. But testicular cancer is the second most common cancer in young men (aged 18 to 39) excluding non-melanoma skin cancer. However, this form of cancer is highly treatable, even when cancer has spread beyond the testicle.

Testicular cancer may cause no symptoms. The most common symptom is a painless swelling or a lump in a testicle.

It is estimated only 928 men will be diagnosed with testicular cancer in Australia in 2020. This equates to 1% of all cancers in men. For Australian men, the risk of being diagnosed with testicular cancer by the age of 90 is 1 in 192. The rate of men diagnosed with testicular cancer has grown by more than 50% over the past 30 years, however the reason for this is not known.

• Change in the size or shape of the testicle;

Germ cell tumours are the most common testicular cancers. Under a microscope there are two main types that are quite different when observed – seminoma and non-seminoma cells. Seminoma cells usually occur in men aged 25-45 but can also occur in men over the age of 60 or at any age. This form of testicular cancer develops more slowly than non-seminoma cancers. The faster developing, rarer form of testicular cancer occurs in younger men in their late teens and early 20s.

40 A LITTLE BELOW THE BELT

Less common symptoms include: • Feeling of heaviness in the scrotum;

• P ain or ache in the lower abdomen, the testicle or scrotum; • Back pain; • Feeling of unevenness; • T enderness or tenderness of the breast tissue (due to hormones created by cancer cells).


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Below the Belt #YourWay

14min
pages 64-75

Good2Give

1min
page 62

ANZUP Trials - Kidney

3min
pages 50-51

ANZUP Trials - Testicular

4min
pages 44-45

ANZUP trials - bladder

2min
pages 37-38

Fiona Stanley Hospital urological surgeon puts songwriting talent to the test for Below the Belt campaign

2min
page 34

Spotlight on bladder and urothelian cancer

1min
page 32

ANZUP Trials - Prostate

1min
page 28

Contents

1min
page 4

How can you get involved?

3min
page 61

2020 Below the Belt Research Fund Recipients

6min
pages 59-60

Trials in follow up

11min
pages 56-58

What are the barriers and facilitators to interdisciplinary models of person-centred supportive care in the context of penile cancer? A mixed methods study

4min
pages 54-55

Spotlight on penile cancer

3min
pages 52-53

A pilot study for Kidney Cancer

4min
pages 49-51

Kidney Cancer and Immunotherapy

2min
page 48

Spotlight on kidney cancer

4min
pages 46-47

Testicular Cancer Research Highlights

9min
pages 42-45

Spotlight on testicular cancer

4min
pages 40-41

The role of the Prostate Cancer Subcommittee

11min
pages 26-31

The importance of data to improve patient outcomes with bladder cancer

4min
pages 36-38

Where are we in demonstrating economic value in prostate cancer trials

3min
page 25

Recruitment nearing completion for world first trial for bladder cancer

1min
page 39

Worldwide prostate cancer trial continues to strongly recruit

2min
page 24

Advanced Prostate Cancer Consensus Conference (APCCC): Asia-Pacific (APAC) Satellite Symposium

2min
page 23

ANZUP’s ENZAMET trial is awarded all three of ACTA’s Trial of the Year Awards

4min
pages 21-22

Finding a clinical pathway during a pandemic

4min
pages 14-16

Spotlight on prostate cancer

4min
pages 19-20

Friends of ANZUP

0
page 13

Consumer Advisory Panel (CAP) Update

6min
pages 9-10

Kev’s Crew

3min
pages 11-12

CEO Update

6min
pages 7-8

Meet Associate Professor Arun Azad

3min
pages 17-18

Message from the Chair, Professor Ian Davis

9min
pages 5-6
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.